From Hype to Hope: CGT Enters the Slope of Enlightenment

Published on Spencer Knight via LinkedIn

CAR-T once promised a revolution, then came the cost, complexity, and clinical setbacks. Spencer Knight reflects on the CGT industry’s path through the classic Gartner Hype Cycle. After years of inflated expectations and disillusionment, 2025 - 2026 is shaping up to be the “Slope of Enlightenment,” where scalable manufacturing and local treatment infrastructure must take center stage. Lowering COGS and boosting care capacity are now critical, not just for success, but for access.

Read the full post on LinkedIn:

👉 Spencer Knight: “I remember the first time I heard about CAR-T therapy…”

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full details, please refer to the original article via the provided link.